Tinel N, Diochot S, Lauritzen I, Barhanin J, Lazdunski M, Borsotto M
Institut de Pharmacologie Moléculaire et Cellulaire, CNRS-UPR 411, Valbonne, France.
FEBS Lett. 2000 Sep 1;480(2-3):137-41. doi: 10.1016/s0014-5793(00)01918-9.
KCNQ2 and KCNQ3 subunits belong to the six transmembrane domain K+ channel family and loss of function mutations are associated with benign familial neonatal convulsions. KCNE2 (MirP1) is a single transmembrane domain subunit first described to be a modulator of the HERG potassium channel in the heart. Here, we show that KCNE2 is present in brain, in areas which also express KCNQ2 and KCNQ3 channels. We demonstrate that KCNE2 associates with KCNQ2 and/or KCNQ3 subunits. In transiently transfected COS cells, KCNE2 expression produces an acceleration of deactivation kinetics of KCNQ2 and of the KCNQ2-KCNQ3 complex. Effects of two previously identified arrhythmogenic mutations of KCNE2 have also been analyzed.
KCNQ2和KCNQ3亚基属于六个跨膜结构域的钾通道家族,功能丧失性突变与良性家族性新生儿惊厥相关。KCNE2(MirP1)是一个单跨膜结构域亚基,最初被描述为心脏中HERG钾通道的调节剂。在这里,我们表明KCNE2存在于大脑中,在那些也表达KCNQ2和KCNQ3通道的区域。我们证明KCNE2与KCNQ2和/或KCNQ3亚基相关联。在瞬时转染的COS细胞中,KCNE2的表达使KCNQ2以及KCNQ2 - KCNQ3复合物的失活动力学加速。我们还分析了先前鉴定的KCNE2的两个致心律失常突变的影响。